Lutathera - Lutetium LU 177 Dotatate – Radiopharmaceuticals - INTENT TO SOLE SOURCE 36C25225Q0635
Summary
AI-generated · Aug 24, 2025Lutathera (Lutetium-177 dotatate) radiopharmaceutical, identified by NDC 69488-0003-01, will be procured under a sole-source, firm-fixed-price contract. The award is intended to be made to Novartis Pharmaceuticals Corporation (a large business) as the sole supplier.
The Department of Veterans Affairs, Network Contracting Office 12, hereby provides notice of its Intent to award a Sole Source, firm fixed price contract NDC number 69488-0003-01 Lutathera - Lutetium LU 177 Dotatate to a large business Novartis Pharmaceuticals Corporation, One Health Plaza East Hanover, NJ 07936-1080.
From Special Notice posted on Jul 29, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA